BMSC-derived exosomal lncRNA PTENP1 suppresses the malignant phenotypes of bladder cancer by upregulating SCARA5 expression

References

• Ruiz M, Cosenza S, Maumus M, Jorgensen C, Noel D. Therapeutic application of mesenchymal stem cells in osteoarthritis. Expert Opin Biol Ther. 2016;16:33–42. doi:10.1517/14712598.2016.1093108.
   PubMed Web of Science ®Google Scholar
• Fu D, Liu B, Jiang H, Li Z, Fan C, Zang L. Bone marrow mesenchymal stem cells-derived exosomal microRNA-19b-1-5p reduces proliferation and raises apoptosis of bladder cancer cells via targeting abl2. Genomics. 2021;113:1338–1348. doi:10.1016/j.ygeno.2021.03.011.
   PubMed Web of Science ®Google Scholar
• Liu W, Wang Y, Gong F, Rong Y, Luo Y, Tang P, Zhou Z, Zhou Z, Xu T, Jiang T, et al. Exosomes derived from bone mesenchymal stem cells repair traumatic spinal cord injury by suppressing the activation of a1 neurotoxic reactive astrocytes. J Neurotrauma. 2019;36(3):469–484. doi:10.1089/neu.2018.5835.
   PubMed Web of Science ®Google Scholar
• He C, Zheng S, Luo Y, Wang B. Exosome theranostics: biology and translational medicine. Theranostics. 2018;8(1):237–255. doi:10.7150/thno.21945.
   PubMed Web of Science ®Google Scholar
• Jiang S, Mo C, Guo S, Zhuang J, Huang B, Mao X. Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of rhpn2. J Exp Clin Cancer Res. 2019;38(1):495. doi:10.1186/s13046-019-1488-1.
   PubMed Web of Science ®Google Scholar
• Cai H, Yang X, Gao Y, Xu Z, Yu B, Xu T, Li X, Xu W, Wang X,Hua L, et al. Exosomal microRNA-9-3p secreted from bmscs downregulates esm1 to suppress the development of bladder cancer. Mol Ther Nucleic Acids. 2019;18:787–800. doi:10.1016/j.omtn.2019.09.023.
   PubMedGoogle Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.21551.
   PubMed Web of Science ®Google Scholar
• Jia Y, Ding X, Zhou L, Zhang L, Yang X. Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting prc1. Oncogene. 2021;40(2):246–261. doi:10.1038/s41388-020-01486-7.
   PubMed Web of Science ®Google Scholar
• Baglio SR, Rooijers K, Koppers-Lalic D, Verweij FJ, Perez Lanzon M, Zini N, Naaijkens B, Perut F, Niessen HWM, Baldini N, et al. Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res Ther. 2015;6(1):127. doi:10.1186/s13287-015-0116-z.
   PubMed Web of Science ®Google Scholar
• Zhao W, Qin P, Zhang D, Cui X, Gao J, Yu Z, Chia Y, Wang J, Li J. Long non-coding RNA pvt1 encapsulated in bone marrow mesenchymal stem cell-derived exosomes promotes osteosarcoma growth and metastasis by stabilizing erg and sponging mir-183-5p. Aging (Albany NY). 2019;11:9581–9596. doi:10.18632/aging.102406.
   PubMedGoogle Scholar
• Leveille N, Baglio SR. Exosome-transferred lncrnas at the core of cancer bone lesions. Crit Rev Oncol Hematol. 2019;139:125–127. doi:10.1016/j.critrevonc.2019.03.002.
   PubMed Web of Science ®Google Scholar
• Fan Y, Sheng W, Meng Y, Cao Y, Li R. Lncrna ptenp1 inhibits cervical cancer progression by suppressing mir-106b. Artif Cells Nanomed Biotechnol. 2020;48:393–407. doi:10.1080/21691401.2019.1709852.
   PubMed Web of Science ®Google Scholar
• Hu S, Xu L, Li L, Luo D, Zhao H, Li D, Peng B. Overexpression of lncrna ptenp1 suppresses glioma cell proliferation and metastasis in vitro. Onco Targets Ther. 2019;12:147–156. doi:10.2147/OTT.S182537.
   PubMed Web of Science ®Google Scholar
• Zhong XL, Wang L, Yan X, Yang XK, Xiu H, Zhao M, Wang X, Liu J. Mir-20a acted as a cerna of lncrna PTEN and promoted bladder cancer cell proliferation and migration by regulating pdcd4. Eur Rev Med Pharmacol Sci. 2020;24:2955–2964. doi:10.26355/eurrev_202003_20660.
   PubMedGoogle Scholar
• Chi Y, Wang D, Wang J, Yu W, Yang J. 2019. Long non-coding RNA in the pathogenesis of cancers. Cells. 8. DOI:10.3390/cells8091015
   Web of Science ®Google Scholar
• Iqbal MA, Arora S, Prakasam G, Calin GA, Syed MA. microRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance. Mol Aspects Med. 2019;70:3–20. doi:10.1016/j.mam.2018.07.003.
   PubMed Web of Science ®Google Scholar
• Ganju A, Khan S, Hafeez BB, Behrman SW, Yallapu MM, Chauhan SC, Jaggi M. miRNA nanotherapeutics for cancer. Drug Discov Today. 2017;22:424–432. doi:10.1016/j.drudis.2016.10.014.
   PubMed Web of Science ®Google Scholar
• Yang C, Yuan W, Yang X, Li P, Wang J, Han J, Tao J, Li P, Yang H, Lv Q, et al. Circular RNA circ-itch inhibits bladder cancer progression by sponging mir-17/mir-224 and regulating p21, PTEN expression. Mol Cancer. 2018;17:19. doi:10.1186/s12943-018-0771-7.
   PubMed Web of Science ®Google Scholar
• Chen CL, Tseng YW, Wu JC, Chen GY, Lin KC, Hwang SM, Hu YC. Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA ptenp1 and microRNA regulation. Biomaterials. 2015;44:71–81. doi:10.1016/j.biomaterials.2014.12.023.
   PubMed Web of Science ®Google Scholar
• You K, Su F, Liu L, Lv X, Zhang J, Zhang Y, Liu B. Scara5 plays a critical role in the progression and metastasis of breast cancer by inactivating the erk1/2, stat3, and akt signaling pathways. Mol Cell Biochem. 2017;435:47–58. doi:10.1007/s11010-017-3055-4.
   PubMed Web of Science ®Google Scholar
• Wen X, Wang N, Zhang F, Dong C. Overexpression of scara5 inhibits tumor proliferation and invasion in osteosarcoma via suppression of the fak signaling pathway. Mol Med Rep. 2016;13:2885–2891. doi:10.3892/mmr.2016.4857.
   PubMed Web of Science ®Google Scholar
• Liu J, Zeng ML, Shi PC, Cao YP, Zhang JL, Xie YP. Scara5 is a novel biomarker in colorectal cancer by comprehensive analysis. Clin Lab. 2020;66. doi:10.7754/Clin.Lab.2019.191015.
   Web of Science ®Google Scholar
• Liu Y, Tan Y-R, Sun -W-W, Ju W-T, Fu Y, Wang L-Z, Li J, Zhang C-P, Zhang Z-Y, Zhong L-P, et al. Identification of scara5 as a potential biomarker for oral squamous cell carcinoma using maldi-tof-ms analysis. Proteomics Clin Appl. 2018;12(5):e1700180. doi:10.1002/prca.201700180.
   PubMed Web of Science ®Google Scholar
• Wang F, Cao X, Yin L, Wang Q, and He Z. Identification of scara5 gene as a potential immune-related biomarker for triple-negative breast cancer by integrated analysis. DNA Cell Biol. 2020;39(10):1813–1824. doi:10.1089/dna.2020.5449.
   Google Scholar
• Baker N, Boyette LB, Tuan RS. Characterization of bone marrow-derived mesenchymal stem cells in aging. Bone. 2015;70:37–47. doi:10.1016/j.bone.2014.10.014.
   PubMed Web of Science ®Google Scholar
• Sun Z, Yang S, Zhou Q, Wang G, Song J, Li Z, Zhang Z, Xu J, Xia K, Chang Y, et al. Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment. Mol Cancer. 2018;17(1):82. doi:10.1186/s12943-018-0831-z.
   PubMed Web of Science ®Google Scholar
• Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F, Ochiya T. Emerging roles of long non-coding RNA in cancer. Cancer Science. 2018;109(7):2093–2100. doi:10.1111/cas.13642.
   PubMed Web of Science ®Google Scholar
• Zheng R, Du M, Wang X, Xu W, Liang J, Wang W, Lv Q, Qin C, Chu H, Wang M, et al. Exosome–transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression. Mol Cancer. 2018;17(1):143. doi:10.1186/s12943-018-0880-3.
   PubMed Web of Science ®Google Scholar
• Wang J, Yang K, Yuan W, Gao Z. Determination of serum exosomal h19 as a noninvasive biomarker for bladder cancer diagnosis and prognosis. Med Sci Monit. 2018;24:9307–9316. doi:10.12659/MSM.912018.
   PubMed Web of Science ®Google Scholar
• Ridge SM, Sullivan FJ, Glynn SA. Mesenchymal stem cells: key players in cancer progression. Mol Cancer. 2017;16(1):31. doi:10.1186/s12943-017-0597-8.
   PubMed Web of Science ®Google Scholar
• Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini F. Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells. 2011;29(1):11–19. doi:10.1002/stem.559. 3rd.
   PubMed Web of Science ®Google Scholar
• Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, et al. Vegfr1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438(7069):820–827. doi:10.1038/nature04186.
   PubMed Web of Science ®Google Scholar
• Biancone L, Bruno S, Deregibus MC, Tetta C, Camussi G. Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transplant. 2012;27(8):3037–3042. doi:10.1093/ndt/gfs168.
   PubMed Web of Science ®Google Scholar
• Li B, Xu H, Han H, Song S, Zhang X, Ouyang L, Qian C, Hong Y, Qiu Y, Zhou W, et al. Exosome-mediated transfer of lncrunx2-as1 from multiple myeloma cells to MSCs contributes to osteogenesis. Oncogene. 2018;37(41):5508–5519. doi:10.1038/s41388-018-0359-0.
   PubMed Web of Science ®Google Scholar
• Li Z, Jiang P, Li J, Peng M, Zhao X, Zhang X, Chen K, Zhang Y, Liu H, Gan L, et al. Tumor-derived exosomal lnc-sox2ot promotes emt and stemness by acting as a cerna in pancreatic ductal adenocarcinoma. Oncogene. 2018;37(28):3822–3838. doi:10.1038/s41388-018-0237-9.
   PubMed Web of Science ®Google Scholar
• Chen C, Luo Y, He W, Zhao Y, Kong Y, Liu H, Zhong G, Li Y, Li J, Huang J, et al. Exosomal long noncoding RNA lnmat2 promotes lymphatic metastasis in bladder cancer. J Clin Invest. 2020;130(1):404–421. doi:10.1172/JCI130892.
   PubMed Web of Science ®Google Scholar
• Yu G, Yao W, Gumireddy K, Li A, Wang J, Xiao W, Chen K, Xiao H, Li H, Tang K, et al. Pseudogene ptenp1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression. Mol Cancer Ther. 2014;13(12):3086–3097. doi:10.1158/1535-7163.MCT-14-0245.
   PubMed Web of Science ®Google Scholar
• Zhang R, Guo Y, Ma Z, Ma G, Xue Q, Li F, Liu L. Long non-coding RNA ptenp1 functions as a cerna to modulate PTEN level by decoying mir-106b and mir-93 in gastric cancer. Oncotarget. 2017;8(16):26079–26089. doi:10.18632/oncotarget.15317.
   PubMedGoogle Scholar
• Qian -Y-Y, Li K, Liu Q-Y, Liu Z-S. Long non-coding RNA ptenp1 interacts with mir-193a-3p to suppress cell migration and invasion through the PTEN pathway in hepatocellular carcinoma. Oncotarget. 2017;8(64):107859–107869. doi:10.18632/oncotarget.22305.
   PubMedGoogle Scholar
• Lu X-S, Huang M-L, Chen L-B, Liu S-C, Huang Z-X, Liu S-M. WITHDRAWN: SCARA5 regulated by MEG3/miR-141 axis attenuates proliferation, migration and invasion of bladder cancer. Life Sci. 2021:119619. doi:10.1016/j.lfs.2021.119619
   PubMedGoogle Scholar